St.Joseph Hospital

Orange, California 92868-4225

3 studies enrolling now · 35 studies all time

What they study most

Adenocarcinoma of the Prostate, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Anaplastic Astrocytoma, Aortic Valve Stenosis, Atherosclerosis, Breast Cancer, Breast Neoplasms, Cardiovascular Diseases, Carotid Artery Disease, Carotid Stenosis, Central Line Associated Blood Stream Infections (CLABSI), Chronic Venous Disorder

Studies at this site

• A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma — Recruiting now
• Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer — Recruiting now
• Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction — Recruiting now
• Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) — Running, not enrolling
• The Merit WRAPSODY AV Access Efficacy Study (WAVE) — Completed
• An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) — Running, not enrolling
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• LIFE-BTK Randomized Controlled Trial — Running, not enrolling
• Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management — Running, not enrolling
• Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System — Completed
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) — Running, not enrolling
• Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries — Paused
• Disrupt CAD III With the Shockwave Coronary IVL System — Completed
• ABRE Clinical Study of the Abre Venous Self-expanding Stent System — Completed
• CAPERE Thrombectomy System Post-Market Clinical Follow Up Study — Stopped early
• SHIELD II Clinical Investigation — Stopped early
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver — Completed
• Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries — Completed
• VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early
• Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA) — Completed
• The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma — Stopped early
• A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer — Withdrawn before enrolling
• Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer — Completed
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis — Completed
• Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I) — Stopped early
• SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension — Completed
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer — Status unconfirmed
• Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
• MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery — Completed
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) — Status unconfirmed
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis — Paused